otomycosis otomycosis treatment
Conditions
Interventions
the control group, which received clotrimazole cream 0.5 mL in the ear canal.,the treatment group, which received combined nystatin, neomycin, gramicidin, and triamcinolone acetonide cream 0.5 mL in t
Active Comparator Drug,Experimental Drug
Clotrimazole cream,combined nystatin, neomycin, gramicidin, and triamcinolone acetonide cream
Sponsors
Faculty of Medicine Chiang Mai University
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Male and female patients aged 20 to 70 years who were recently diagnosed with otomycosis with no history of otomycosis within the previous 3 months. 2. Immunocompetent patient 3. Participants had provided written informed consent to study participation.
Exclusion criteria
Exclusion criteria: 1. Patient with a history of middle ear surgery such as mastoidectomy. 2. Patient with abnormal anatomy of EAC. 3. Patient with concomitant chronic otitis media or tympanic membrane perforation. 4. Patient with bilateral otomycosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The complete endoscopic response rate 10-14days otoendoscopic examination | — |
Secondary
| Measure | Time frame |
|---|---|
| symptoms score 10-14days Likert score | — |
Countries
Thailand
Contacts
Public ContactTaksinawadee Ratanayon
Faculty of Medicine, Chiang Mai University
Outcome results
None listed